Correlation between post-vaccination titres of combined IgG, IgA, and IgM anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study (COVIDENCE UK)
View ORCID ProfileGiulia Vivaldi, View ORCID ProfileDavid A Jolliffe, View ORCID ProfileSian Faustini, Hayley Holt, Natalia Perdek, View ORCID ProfileMohammad Talaei, Florence Tydeman, Emma S Chambers, Weigang Cai, Wenhao Li, Joseph M Gibbons, Corinna Pade, Áine McKnight, View ORCID ProfileSeif O Shaheen, View ORCID ProfileAlex G Richter, View ORCID ProfileAdrian R Martineau
doi: https://doi.org/10.1101/2022.02.11.22270667
Giulia Vivaldi
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
David A Jolliffe
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Sian Faustini
3Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Hayley Holt
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
4Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK
Natalia Perdek
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mohammad Talaei
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Florence Tydeman
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Emma S Chambers
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Weigang Cai
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Wenhao Li
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Joseph M Gibbons
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Corinna Pade
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Áine McKnight
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Seif O Shaheen
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Alex G Richter
3Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Adrian R Martineau
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
4Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK
Article usage
Posted February 13, 2022.
Correlation between post-vaccination titres of combined IgG, IgA, and IgM anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study (COVIDENCE UK)
Giulia Vivaldi, David A Jolliffe, Sian Faustini, Hayley Holt, Natalia Perdek, Mohammad Talaei, Florence Tydeman, Emma S Chambers, Weigang Cai, Wenhao Li, Joseph M Gibbons, Corinna Pade, Áine McKnight, Seif O Shaheen, Alex G Richter, Adrian R Martineau
medRxiv 2022.02.11.22270667; doi: https://doi.org/10.1101/2022.02.11.22270667
Correlation between post-vaccination titres of combined IgG, IgA, and IgM anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study (COVIDENCE UK)
Giulia Vivaldi, David A Jolliffe, Sian Faustini, Hayley Holt, Natalia Perdek, Mohammad Talaei, Florence Tydeman, Emma S Chambers, Weigang Cai, Wenhao Li, Joseph M Gibbons, Corinna Pade, Áine McKnight, Seif O Shaheen, Alex G Richter, Adrian R Martineau
medRxiv 2022.02.11.22270667; doi: https://doi.org/10.1101/2022.02.11.22270667
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2344)
- Dermatology (206)
- Emergency Medicine (376)
- Epidemiology (11721)
- Forensic Medicine (10)
- Gastroenterology (697)
- Genetic and Genomic Medicine (3698)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2378)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3460)
- Nursing (195)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (416)
- Public and Global Health (6099)
- Radiology and Imaging (1264)
- Respiratory Medicine (822)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)